You are here

  • Home
  • Archive
  • Volume 94, Issue 8
  • Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina

Article Text

Article menu
Download PDFPDF
Original article
Acute coronary syndromes
Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina
  1. S Miyamoto1,
  2. M Ueda2,
  3. M Ikemoto3,
  4. T Naruko4,
  5. A Itoh4,
  6. S Tamaki5,
  7. R Nohara1,
  8. F Terasaki6,
  9. S Sasayama7,
  10. M Fujita3
  1. 1
    Division of Cardiology, Kitano Hospital, Tadukekofukai Medical Research Institute, Osaka, Japan
  2. 2
    Department of Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
  3. 3
    Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
  4. 4
    Department of Cardiology, Osaka City General Hospital, Osaka, Japan
  5. 5
    Division of Cardiology, Takeda Hospital, Kyoto, Japan
  6. 6
    Third Department of Internal Medicine, Osaka Medical College, Takatsuki, Japan
  7. 7
    Heart Bio-Mechanics Centre, Doshisha University, Kyoto, Japan
  1. Professor M Fujita, Human Health Sciences, Kyoto University Graduate School of Medicine, 53 Kawaharacho, Shogoin, Sakyo-ku, Kyoto 606–8507, Japan; mfujita{at}kuhp.kyoto-u.ac.jp

Abstract

Background: The S100A8/A9 complex is expressed in a subset of activated neutrophils and macrophages in acute inflammatory lesions associated with various diseases.

Objective: To investigate (a) whether serum S100A8/A9 levels are increased in patients with unstable angina (UA); and (b) whether S100A8/A9 expression is upregulated in coronary atherosclerotic plaques of patients with UA.

Design: Serum S100A8/A9 levels in 39 patients with stable angina (SA) and 53 patients with UA were measured. In addition, the presence of the S100A8/A9 complex in directional coronary atherectomy specimens was studied immunohistochemically. Cell types which stain positive for S100A8/A9 were identified by immunodouble staining with neutrophils and macrophages.

Results: Mean (SD) serum S100A8/A9 levels were significantly higher in patients with UA than in those with SA (3.25 (3.08) μg/ml vs 0.77 (0.31) μg/ml, p<0.05). In patients with UA, immunodouble staining clearly showed that the S100A8/A9 complex was expressed in infiltrated neutrophils and occasional macrophages. The S100A8/A9-positive area was significantly higher in UA than in SA (mean (SD) 18.3 (14.2)% vs 1.3 (2.4)%, respectively, p<0.001).

Conclusions: The S100A8/A9 complex may be involved in the inflammatory process of coronary atherosclerotic plaques in patients with UA.

https://doi.org/10.1136/hrt.2007.121640

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests: None declared.

    • Ethics approval: Study protocol approved by the institutional review committees of Takeda Hospital and Osaka City General Hospital.

    • ▸ An additional figure is published online only at http://heart.bmj.com/content/vol94/issue8